Sanofi, GSK, Boehringer Ingelheim, Pfizer
Tech
1
Settlement
$300M
Total Paid
2026
Last Settled
Based on 1 class action settlement in our database, Sanofi, GSK, Boehringer Ingelheim, Pfizer earns a grade of D on corporate accountability.
D
Grade
55/100
Grade Breakdown
📊
Settlements on Record
1
30% of grade
💰
Total Settlement Amount
$300.0M
25% of grade
⚠️
Severity Score
70/100
20% of grade — higher is better
📅
Recency Score
15/100
15% of grade — recent settlements hurt more
All Settlements Involving Sanofi, GSK, Boehringer Ingelheim, Pfizer
Zantac (Ranitidine) Cancer Settlement
Manufacturers of Zantac heartburn medication face claims that the drug contained NDMA, a probable human carcinogen, and failed to warn consumers about cancer risks.
Amount: TBD (Est. $10B+)
Deadline: Dec 31, 2026
🔔
Watch Sanofi, GSK, Boehringer Ingelheim, Pfizer
Get notified when new settlements involving Sanofi, GSK, Boehringer Ingelheim, Pfizer are filed or when their grade changes.
Set Up Alert